Citadel Advisors - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$65,777
-67.1%
34,988
-37.2%
0.00%
Q2 2023$199,966
+57.4%
55,701
+47.8%
0.00%
Q1 2023$127,022
-54.3%
37,692
-70.3%
0.00%
Q2 2022$278,000
+280.8%
126,898
+461.4%
0.00%
Q1 2022$73,000
-16.1%
22,602
+8.5%
0.00%
Q4 2021$87,000
-85.6%
20,822
-72.1%
0.00%
Q3 2021$606,000
-21.1%
74,557
-26.7%
0.00%
Q2 2021$768,000
+16.2%
101,715
+33.6%
0.00%
Q1 2021$661,000
-20.0%
76,138
-26.5%
0.00%
Q4 2020$826,000
-46.3%
103,606
-46.3%
0.00%
Q3 2020$1,539,000
-17.6%
193,003
+2.3%
0.00%
Q2 2020$1,868,000
+251.1%
188,639
+174.0%
0.00%
Q1 2020$532,000
+401.9%
68,847
+149.0%
0.00%
Q4 2019$106,000
-12.4%
27,651
+72.4%
0.00%
Q1 2019$121,000
-32.0%
16,037
-27.1%
0.00%
Q4 2018$178,000
+2.3%
22,000
+63.0%
0.00%
Q3 2018$174,000
-40.6%
13,500
-47.5%
0.00%
Q2 2018$293,000
+7.7%
25,700
-33.1%
0.00%
Q1 2018$272,000
+68.9%
38,391
+55.4%
0.00%
Q4 2017$161,000
+75.0%
24,700
+65.8%
0.00%
Q3 2017$92,000
-13.2%
14,900
-9.8%
0.00%
Q3 2016$106,000
+100.0%
16,527
+95.6%
0.00%
Q3 2015$53,000
-15.9%
8,451
-17.9%
0.00%
Q2 2015$63,00010,2940.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 675,000$918,0001.02%
Sargent Investment Group, LLC 1,108,233$2,028,0000.63%
Skylands Capital, LLC 2,347,034$3,192,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,000$344,0000.37%
Avenir Corp 2,314,854$3,148,0000.33%
Granahan Investment Management 1,511,029$2,055,0000.07%
ACT CAPITAL MANAGEMENT, LLC 35,000$48,0000.07%
Winning Points Advisors, LLC 22,900$33,0000.04%
Cowen Prime Advisors LLC 42,200$57,0000.03%
Seelaus Asset Management LLC 23,900$33,0000.03%
View complete list of CYTOSORBENTS CORP shareholders